Skip to content
GenoLensGenoLens

KDSR

Chr 18q21.33

3-ketodihydrosphingosine reductase

Aliases:
DHSR, SDR35C1
MANE:
ENST00000645214.2

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Bleeding and platelet disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Ichthyosis and erythrokeratoderma

    BIALLELIC, autosomal or pseudoautosomal
  • Inherited bleeding disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Palmoplantar keratoderma and erythrokeratodermas

    BIALLELIC, autosomal or pseudoautosomal
  • Palmoplantar keratodermas

    BIALLELIC, autosomal or pseudoautosomal
  • Cytopenia - NOT Fanconi anaemia

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • erythrokeratodermia variabilis et progressiva 4

    0.78
  • erythrokeratodermia variabilis

    0.46
  • prostate carcinoma

    0.42
  • blood platelet disease

    0.37
  • neurodegenerative disease

    0.36
  • lymphoid neoplasm

    0.19
  • B-cell chronic lymphocytic leukemia

    0.19
  • hereditary disease

    0.19
  • plasma cell myeloma

    0.19
  • breast carcinoma

    0.19

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

3-ketodihydrosphingosine reductase

Catalyzes the reduction of 3'-oxosphinganine (3-ketodihydrosphingosine/KDS) to sphinganine (dihydrosphingosine/DHS), the second step of de novo sphingolipid biosynthesis

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.